Clinical trial Recruiting at 6 sites Interventional Ages 18 and up

Nephroprotection for severe trauma patients with early urine signs of kidney stress

Official title: Impact of a Nephroprotection Bundle-of-care in Severe Trauma Patients at Risk of Acute Kidney Injury: a Multicenter Randomized Controlled Trial

Run by Hospices Civils de Lyon · NCT06834633 · Data updated 2026-11-12

This trial tests whether giving an early nephroprotection bundle to adults with severe trauma and a urine biomarker showing kidney stress can reduce acute kidney injury.

More Postoperative Complications trials

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment523 (estimated)
SponsorHospices Civils de Lyon
Academic / other
Locations6 sites (Clermont-Ferrand and 5 other locations)
StatusRecruiting
StartedJuly 9, 2025
Main results expectedSeptember 2027
Study endsSeptember 2027
Registry record updatedJuly 29, 2026
Trial IDNCT06834633 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults (≥18) with severe trauma (ISS >15) admitted to a participating trauma center within 6 hours who have an indwelling urinary catheter and an NC urine score >0.3 measured within 12 hours are the intended participants.

Probably not a fit

Patients already meeting clinical AKI criteria, those admitted more than 6 hours after injury, those without a urinary catheter, pregnant or breastfeeding patients, and those under legal restriction are unlikely to benefit or are excluded.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study enrolls adults with severe trauma (ISS >15) admitted within 6 hours who have an elevated urine NC score (>0.3) measured within 12 hours of ICU admission. Eligible patients are assigned to receive either standard care or a systematic nephrotection bundle-of-care initiated promptly after the biomarker result. The bundle follows guideline-recommended steps such as hemodynamic optimization, avoidance of nephrotoxins, and close urine/output and creatinine monitoring, applied early to try to stop reversible cellular kidney stress. Outcomes focus on preventing progression to acute kidney injury in the early post-trauma period and during the hospital stay.

Why it matters

Potential benefit: If successful, this approach could lower the number and severity of acute kidney injury episodes after severe trauma by enabling earlier protective care.

How similar studies have gone: Randomized trials in major surgical patients have shown early nephroprotection bundles can reduce severe AKI within 72 hours, but their application specifically in severe trauma patients is less well tested.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Adult patient (≥ 18 years)
* Severe trauma patients (ISS score \> 15) admitted to a trauma center
* Time between trauma and admission to trauma center \<6h
* High risk of AKI: at least one NC score greater than 0.3 within 12 hours of admission to critical care (intensive care and continuous monitoring unit)
* Affiliated with a social security scheme or beneficiary of a similar scheme
* Consent signed by patient or close relative, or attestation signed by investigator in case of emergency

Exclusion Criteria:

* Adult under legal protection (guardianship, curators)
* Persons deprived of their liberty by judicial or administrative decision
* Patients taking part in other interventional research which may interfere with the research and which includes an exclusion period still in progress at the time of inclusion.
* Pregnant or breast-feeding woman (diagnosis of pregnancy by plasma βHCG (Beta-Human Chorionic Gonadotropin) assay routinely performed as part of the blood test on admission to the outpatient department of a woman of childbearing age).
* Patients with end-stage or severe chronic renal failure with Glomerular Filtration Rate (GFR) \< 30 milliliters/min/1.73m2 or chronic dialysis.
* Anuric patients
* Severe heart failure defined as Left Ventricular Ejection Fraction (LVEF) \<25%.
* Patient moribund on admission with an estimated length of stay of less than 24 hours
* Patient with AKI at time of randomization (developed prior to ICU admission or within the first 12 hours of ICU admission, before randomization).

Where it's running

  • Centre Hospitalier universitaire Estaing, Service anesthésie-réanimation
    Clermont-Ferrand, France
    Recruiting
  • Centre hospitaler Annecy Genevois, Service de réanimation
    Épagny, France
    Recruiting
  • Centre hospitalier universitaire de Grenoble Alpes, Pôle anesthésie-réanimation
    La Tronche, France
    Recruiting
  • Hospices Civils de Lyon, Hôpital Edouard Herriot, Service d'anesthésie-réanimation
    Lyon, France
    Recruiting
  • Hospices Civils de Lyon, Hôpital Lyon-Sud, Service d'anesthésie-réanimation
    Pierre-Bénite, France
    Recruiting
  • Centre hospitalier universitaire de Saint Etienne, Hôpital Bellevue, Service anesthésie-réanimation
    Saint-Etienne, France
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.